334 related articles for article (PubMed ID: 28644039)
1. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.
Gwinn K; David KK; Swanson-Fischer C; Albin R; Hillaire-Clarke CS; Sieber BA; Lungu C; Bowman FD; Alcalay RN; Babcock D; Dawson TM; Dewey RB; Foroud T; German D; Huang X; Petyuk V; Potashkin JA; Saunders-Pullman R; Sutherland M; Walt DR; West AB; Zhang J; Chen-Plotkin A; Scherzer CR; Vaillancourt DE; Rosenthal LS
Biomark Med; 2017 May; 11(6):451-473. PubMed ID: 28644039
[TBL] [Abstract][Full Text] [Related]
2. The NINDS Parkinson's disease biomarkers program.
Rosenthal LS; Drake D; Alcalay RN; Babcock D; Bowman FD; Chen-Plotkin A; Dawson TM; Dewey RB; German DC; Huang X; Landin B; McAuliffe M; Petyuk VA; Scherzer CR; Hillaire-Clarke CS; Sieber BA; Sutherland M; Tarn C; West A; Vaillancourt D; Zhang J; Gwinn K;
Mov Disord; 2016 Jun; 31(6):915-23. PubMed ID: 26442452
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
Nalls MA; McLean CY; Rick J; Eberly S; Hutten SJ; Gwinn K; Sutherland M; Martinez M; Heutink P; Williams NM; Hardy J; Gasser T; Brice A; Price TR; Nicolas A; Keller MF; Molony C; Gibbs JR; Chen-Plotkin A; Suh E; Letson C; Fiandaca MS; Mapstone M; Federoff HJ; Noyce AJ; Morris H; Van Deerlin VM; Weintraub D; Zabetian C; Hernandez DG; Lesage S; Mullins M; Conley ED; Northover CA; Frasier M; Marek K; Day-Williams AG; Stone DJ; Ioannidis JP; Singleton AB;
Lancet Neurol; 2015 Oct; 14(10):1002-9. PubMed ID: 26271532
[TBL] [Abstract][Full Text] [Related]
4. Clinical Progression of Parkinson's Disease: Insights from the NINDS Common Data Elements.
Lewis MM; Harkins E; Lee EY; Stetter C; Snyder B; Corson T; Du G; Kong L; Huang X
J Parkinsons Dis; 2020; 10(3):1075-1085. PubMed ID: 32538866
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
Posavi M; Diaz-Ortiz M; Liu B; Swanson CR; Skrinak RT; Hernandez-Con P; Amado DA; Fullard M; Rick J; Siderowf A; Weintraub D; McCluskey L; Trojanowski JQ; Dewey RB; Huang X; Chen-Plotkin AS
PLoS Med; 2019 Oct; 16(10):e1002931. PubMed ID: 31603904
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning.
Severson KA; Chahine LM; Smolensky LA; Dhuliawala M; Frasier M; Ng K; Ghosh S; Hu J
Lancet Digit Health; 2021 Sep; 3(9):e555-e564. PubMed ID: 34334334
[TBL] [Abstract][Full Text] [Related]
7. Seeking progress in disease modification in Parkinson disease.
Lungu C; Cedarbaum JM; Dawson TM; Dorsey ER; Faraco C; Federoff HJ; Fiske B; Fox R; Goldfine AM; Kieburtz K; Macklin EA; Matthews H; Rafaloff G; Saunders-Pullman R; Schor NF; Schwarzschild MA; Sieber BA; Simuni T; Surmeier DJ; Tamiz A; Werner MH; Wright CB; Wyse R
Parkinsonism Relat Disord; 2021 Sep; 90():134-141. PubMed ID: 34561166
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson's Disease.
Gupta DK; Marano M; Zweber C; Boyd JT; Kuo SH
Tremor Other Hyperkinet Mov (N Y); 2020 Dec; 10():58. PubMed ID: 33384882
[TBL] [Abstract][Full Text] [Related]
9. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
Kang UJ; Goldman JG; Alcalay RN; Xie T; Tuite P; Henchcliffe C; Hogarth P; Amara AW; Frank S; Rudolph A; Casaceli C; Andrews H; Gwinn K; Sutherland M; Kopil C; Vincent L; Frasier M
Mov Disord; 2016 Jun; 31(6):924-32. PubMed ID: 27113479
[TBL] [Abstract][Full Text] [Related]
10. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease biomarkers program brain imaging repository.
Ofori E; Du G; Babcock D; Huang X; Vaillancourt DE
Neuroimage; 2016 Jan; 124(Pt B):1120-1124. PubMed ID: 25976927
[TBL] [Abstract][Full Text] [Related]
12. Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person.
Chahine LM; Chin I; Caspell-Garcia C; Standaert DG; Brown E; Smolensky L; Arnedo V; Daeschler D; Riley L; Korell M; Dobkin R; Amondikar N; Gradinscak S; Shoulson I; Dean M; Kwok K; Cannon P; Marek K; Kopil C; Tanner CM; Marras C;
J Parkinsons Dis; 2020; 10(2):677-691. PubMed ID: 31958097
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington.
Watson GS; Cholerton BA; Gross RG; Weintraub D; Zabetian CP; Trojanowski JQ; Montine TJ; Siderowf A; Leverenz JB
Alzheimers Dement; 2013 Sep; 9(5):609-14. PubMed ID: 23164549
[TBL] [Abstract][Full Text] [Related]
14. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
[TBL] [Abstract][Full Text] [Related]
15. Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.
Elm JJ;
Mov Disord; 2012 Oct; 27(12):1513-21. PubMed ID: 23079770
[TBL] [Abstract][Full Text] [Related]
16. Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.
Wills AA; Elm JJ; Ye R; Chou KL; Parashos SA; Hauser RA; Bodis-Wollner I; Hinson VK; Christine CW; Schneider JS;
Parkinsonism Relat Disord; 2016 Dec; 33():127-133. PubMed ID: 27743701
[TBL] [Abstract][Full Text] [Related]
17. NINDS boosts research for biomarkers in Parkinson's disease.
Lancet Neurol; 2013 Mar; 12(3):217. PubMed ID: 23415560
[No Abstract] [Full Text] [Related]
18. Progression marker of Parkinson's disease: a 4-year multi-site imaging study.
Burciu RG; Ofori E; Archer DB; Wu SS; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
Brain; 2017 Aug; 140(8):2183-2192. PubMed ID: 28899020
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson's Disease.
Hepp DH; van Wageningen TA; Kuiper KL; van Dijk KD; Oosterveld LP; Berendse HW; van de Berg WDJ
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834363
[TBL] [Abstract][Full Text] [Related]
20. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
